Tower Health’s Reading Hospital has now been approved to offer the new COVID-19 treatment, bamlanivimab, the monocolonal antibody developed by Eli Lilly that is similar to the treatment President Donald Trump was given when he contracted the virus.
Read More »The experimental drug, which was developed by Eli Lilly, is similar to the product that was given to President Donald Trump after contracting the virus last month.
Read More »
© 2021 BridgeTower Media. All information on this site is copyrighted by BridgeTower Media.
All images are the sole property of BridgeTower Media and no rights are granted for any use without the express written consent of BridgeTower Media.